Alison Moskowitz presented results of a Phase 1 study of combination duvelisib plus ruxolitinib in relapsed/refractory (R/R) peripheral T-cell lymphoma or cutaneous T-cell lymphoma ... for the ...
AbbVie announced groundbreaking results today from its latest Emotional Impact Report (EIR), a patient survey that provides an understanding of the ...
Sarah Cannon Research Institute (SCRI) announced today that more than 65 abstracts and presentations have been accepted for the 66th American Society ...